Seeing Is Believing
with an average price target of $12.29. This is a potential upside of $5.19 (73.1%) from yesterday's end of day stock price of $7.1.
LogicBio Therapeutics's activity chart (see below) currently has 4 price targets and 6 ratings on display.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 94.75 days.
Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 10-May-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2
$-5.1 (-71.83%)
$16
2 years 6 months 14 days ago
(10-May-2022)
3/3 (100%)
$1.54 (334.78%)
379
Buy
$8
$5.93 (286.47%)
3 years 7 days ago
(17-Nov-2021)
0/1 (0%)
$4.53 (130.55%)
Buy
$26
$23.93 (1156.04%)
$26
4 years 10 months 14 days ago
(10-Jan-2020)
0/3 (0%)
$14.67 (150.78%)
What is LOGC (LogicBio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LOGC (LogicBio Therapeutics) with a proven track record?
Which analyst has the current lower performing score on LOGC (LogicBio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most bullish on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most reserved on LOGC (LogicBio Therapeutics)?